Corneal Implants Market Worth $641.41 Million By 2027

The global corneal implants market size is anticipated to reach USD 641.41 million by 2027 registering a CAGR of 6.5%, according to a new report by Grand View Research, Inc. Rising prevalence of corneal diseases, such as keratoconus, Fuchs dystrophy, and infectious keratitis, is the major factor driving the market growth.

The gap between demand and supply is also expected to boost the market growth in the long run. Various programs spreading awareness about the importance of corneal donation are also likely to support market growth. Moreover, many European countries are adopting “opt-out” policy for organ donation to meet the growing demand for corneal grafts.

Increasing number of R&D activities related to corneal implants is expected to foster the market growth over the forecast period. Bioengineered cornea, 3D printed cornea, and stem cells therapy are few of the topics gaining attention from the stakeholders.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/corneal-implants-market

Further key findings from the study suggest:

Based on type, human cornea segment held the largest market share in 2019 and is estimated to retain its dominant position throughout the forecast period
Lack of accessibility, shortage of human corneas, and rising number of graft rejection cases are factors expected to drive the segment growth
Based on end user, the hospital segment held the largest market share in 2019 and is expected to have a significant growth rate over the forecast period
North America holds the largest market share in the global market. U.S, is one of the major suppliers of corneal Implant globally
Asia pacific are expected to witness the fastest CAGR over the forecast period due to rising demand for corneal implants in countries, such as China, Indonesia, and Philippines
Endothelial keratoplasty segment is expected to register the fastest CAGR from 2020 to 2027 owing benefits, such as faster and better visual restoration with decreased risk of infection and accidents to the eye surface
Based on application, Fuchs Dystrophy segment held the largest market share in 2019 and is expected to register the fastest CAGR from 2020 to 2027
This growth can be attributed to the factors, such as rising adoption of minimally invasive surgical procedures and high prevalence of the disease

Surgical Light Market Size Worth $2.2 Billion By 2026

The global surgical lights market size is expected to reach USD 2.2 billion by 2026, registering a CAGR of 4.6% during the forecast period, according to a new report by Grand View Research, Inc. Increasing demand for latest technologies to provide patients the best possible care coupled with rising number of surgical procedures around the globe is expected to fuel the growth.

Surgical lights are mainly used in Ambulatory Surgery Centers (ASCs) and hospitals. They are used by surgeons, clinicians, and proceduralists for optimal visualization during a medical procedure. The lights can also be used in emergency rooms, labor and delivery, and examination rooms. A rise in the number of surgeries due to the high prevalence of cardiovascular diseases, neurological disorders, and accidents and trauma cases is anticipated to drive the demand for surgical lights in the forthcoming years. According to a 2016 report of the World Health Organization (WHO), the number of surgeries increased by ~40% from 2004 to 2012.

North America and Europe have led the surgical light market in terms of both the revenue and volume share, owing to the availability of a large number of advanced and progressive healthcare facilities and growing number of ambulatory surgery centers in the regions. In Asia Pacific, the adoption of surgical lights is rising at a significant rate, due to increasing number of well-equipped healthcare facilities in the region.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/surgical-lights-market

Further key findings from the study suggest:

Hospitals and ambulatory surgical centers prefer LED surgical lights due to advantages over halogen lights, such as energy-efficiency, less energy consumption, and longer shelf life
Government initiatives for promoting the adoption of energy-efficient surgical lamps in hospitals and ambulatory surgical centers along with increasing R&D efforts for advancements in surgical lights is driving the market
North America dominated the market with the largest revenue share of 38.7% in 2018. This is due to the increasing number of ambulatory surgical centers for outpatient surgical procedures and growing trend for hybrid operating rooms in U.S.
Asia Pacific is expected to witness the fastest CAGR of 6.4% over the forecast period. Improvement of healthcare infrastructure is attributed to the increasing demand for surgical devices, equipment, and accessories
Few of the surgical lights market players are STERIS plc; A-dec Inc.; BihlerMED; CV Medical; SKYTRON; Herbert Waldmann GmbH & Co. KG; Getinge AB; Hill-Rom Services; S.I.M.E.O.N. Medical GmbH & Co. KG; and Integra LifeSciences Corporation

Payment Security Market Worth $43.76 Billion By 2025

The global payment security market size is expected to reach USD 43.76 billion by 2025, according to a new report by Grand View Research, Inc., progressing at a CAGR of 12.3% during the forecast period. Rising need for PCI DSS (payment card industry data security standard) compliance and adoption of digital payment mode by consumers are likely to stoke the growth of the market. The payments industry is going through a movement of infrastructure transformation, which is essential to compete efficiently with non-bank trendsetters and address progressing customer requirements.

Over the past few years, major economies have modernized their payment infrastructures and many others are scheduling to upgrade. Digital payments aid merchants in maintaining continuous compliance with PCI DSS, which is further anticipated to bolster the growth of the payment security market. In March 2015, Worldpay noted over 133,000 fraudulent transactions reported, which interpreted stolen card details being used every 20 seconds. Thus, payment security providers help its customer’s systems to protect itself from threats and aim to provide secure businesses by getting them to comply with PCI DSS. Therefore, the payment security market is estimated to be driven by the adoption of PCI DSS compliance.

Fraud detection and prevention solutions hold the largest share in the overall market. These solutions provide various fraud analytics solutions such as big data and predictive analytics. Big data and predictive analytics helps to detect and avoid frauds.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/payment-security-market

Further key findings from the report suggest:

The global payment security market had a valuation of USD 15.79 billion in 2017
Encryption platform emerged as the fastest growing segment over the forecast period
Large enterprises represented the leading segment in terms of organization in 2017 and are projected to generate revenue over USD 29.80 billion by 2025
The education market is poised to witness the highest CAGR of 13.4% over the forecast period
North America was the leading revenue contributor in 2017. Rising number of startups in the retail industry and presence of prominent payment security providers in the region is expected to drive the North America payment security market
Key players include Braintree, CyberSource, Ingenico, and Index among others. These players commanded the leading revenue share in the market in 2017.

Blood Collection Market Size Worth $13.99 Billion By 2026

The global blood collection market size is expected to reach a value of USD 13.99 billion by 2026, expanding at a CAGR of 6.6%, according to a new report by Grand View Research, Inc. Rising incidence of infectious and non-communicable diseases is a major factor anticipated to propel the market growth during the forecast period.

According to the World Health Organization, over 41 million individuals that are equivalent to almost 71% of global deaths were caused due to non-communicable diseases in 2018. Cardiovascular diseases registered the highest mortality rates of over 17.9 million followed by cancer that claimed 9 million deaths and respiratory diseases such as chronic obstructive pulmonary disease & asthma claimed over 3.9 million lives in 2017 globally. These facts are indicative of an increase in the incidence of non-communicable diseases, which is expected to fuel market growth.

An increase in the number of road accidents is anticipated to lead to a rise in demand for blood and its components. According to the National Trauma Institute, trauma injuries account for 30% of lives lost globally. The economic burden due to trauma injuries accounts for nearly USD 671 billion in a year. Statistics from the same source indicate that trauma is the number one cause of death from the age of 1 to 46. These facts are indicative of the rising incidence of trauma injuries that require blood collection products for effective treatment.

The growing rate of novel product launches and investments are anticipated to fuel the market growth during the forecast period. For instance, in August 2019, Velano Vascular announced that the company received an investment of USD 10 million from its strategic investor, Intermountain Healthcare for Velano Vascular’s FDA cleared PIVO needle-free blood collection technology.

PIVO device temporarily attaches itself to a peripheral IV catheter that collects the fresh venous sample. This device uses disposable needle-free that caters to lowered risks, improved quality of care, and increased efficiency. Therefore, the use of such novel technologies to avoid painful blood collection methods is expected to fuel market growth.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/blood-collection-market

Further Key Findings from the Study Suggest:

Blood collection tubes witnessed huge demand owing to its increasing usage in diagnostics and blood sampling, thus, generated largest revenue in the year 2018
Treatment application is anticipated to gain significant market share in the near future owing to rising incidence of chronic diseases
The diagnostics application segment held the largest revenue share in 2018, due to the expanding pool of geriatric population and escalating prevalence of infectious & non-communicable diseases
In 2018, the hospitals segment accounted for the largest share in the market due to an upsurge in the incidence of trauma & accidental cases along with growing number of surgical procedures
North America held the largest share of the blood collection market in the year 2018, which can be attributed to the presence of a highly developed healthcare infrastructure and advanced blood collection products.
Some of the key companies include Abbott Laboratories, NIPRO Medical Corp., Becton, Dickinson and Company, Terumo Corp., Medtronic, Qiagen, and FL MEDICAL s.r.l.

Net-Zero Energy Buildings Market Size Worth $78.79 Billion By 2025

The global net-zero energy buildings (NZEBs) market is projected to reach USD 78.79 billion by 2025, according to the new report by Grand View Research, Inc. Net-zero energy buildings are those buildings where ideally 100% of their energy is generated and met with onsite renewable energy sources, thereby reducing the energy consumption over a span of time. ZNE (Zero Net Energy) buildings include ZNE emerging and ZNE verified buildings.

ZNE verified buildings are those buildings that meet the net energy consumption through onsite renewable energy technologies over a course of time. The energy is produced from onsite renewables instead of fuels such as electric, natural gas, and steam. Whereas ZNE emerging buildings have specified targets for achieving nearly-zero energy but are yet to meet the goals as per the definition of ZNE verified buildings. Such emerging buildings are usually in the planning or designing phase or under construction with less than one year of operation.

Technological advancements coupled with stringent policies and programs are expected to considerably propel the demand and adoption of NZEBs. ZNE projects are targeting buildings such as schools, institutional buildings, corporate offices, and public buildings across the globe. The market is expected to gain traction over the forecast period on account of specified targets and regulations laid down by organizations striving to achieve sustainability and reducing carbon emissions. The U.S. consists of relatively more verified and emerging ZNE buildings than other countries. Projects are being undertaken to convert the districts into nearly-zero energy buildings and green buildings.

The regional laws, authorities, bodies, organizations, concerned government departments are working with regional architects, designers, builder & contractors, equipment manufacturers, and material suppliers to promote self-energy sufficient buildings. The large number of successful projects with the use of current technologies and design approaches have created awareness among the population regarding how realistic and achievable the net-zero energy goals are.

The industry is gaining momentum and is predicted to exhibit robust growth, creating lucrative opportunities for equipment producers, material suppliers, and service providers. HVAC systems are one of the most important and energy-consuming parts in the entire building structure. The HVAC systems segment accounted for the largest market share and is anticipated to continue dominating the market over the forecast period.

The consulting & designing services segment is expected to grow at a notable rate and generate healthy revenue over the estimated duration. Furthermore, local and regional organizations are shifting their focus on the residential sector, which is also expected to drive the segment growth. The European region is likely to project a robust growth rate owing to the rising concerns for environment protection, stringent policies, building codes, and sustainability goals stated by the governments of the countries in this region. Large investments made by regional manufacturers and keen emphasis by the monitoring authorities on the adoption of net-zero energy buildings are the major influencing factors for the regional market’s substantial growth over the forecast period.

In addition to the analysis of global net-zero energy buildings market trends, the report highlights the opportunities and barriers involved in achieving net-zero energy targets. Moreover, it provides a review on the investor opportunities with key questions answered from an investor’s perspective. It also explains the significance of green buildings in improving a business.

Owing to the potential opportunities of the regional market, the energy performance and requirements for different climatic zones, particularly in the European region, is explained in the report. The U.S. accounted for the largest market share in 2016 on account of the large number of ZNE buildings in the country. As such, a list of ZNE verified buildings is provided so as to understand the country’s pattern of adopting the technological concept along with its future demands for net-zero emerging buildings.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/net-zero-energy-buildings-nzebs-market

Further key findings from the report suggest:

The net-zero energy is achievable globally with appropriate building codes, regulations, and monitoring irrespective of the climatic conditions and zones.
The ecological sustainability concept of NZEBs is applicable for almost all building types and sizes, including institutional buildings, university buildings, corporate offices, high-rise and low-rise apartments or bungalows, and manufacturing plants.
Upcoming U.S. projects to convert districts into net-zero energy buildings are expected to lead the country to capture a large market share over the forecast period.
The growing emphasis on converting or refurbishing existing buildings into self-sustainable ones is predicted to drive the market considerably.
The private sector is expected to witness wide opportunities from the globally increasing demand for ZNE infrastructure.
The residential buildings segment is expected to exhibit robust growth over the forecast period.
The walls & roofs segment is anticipated to grow considerably owing to the increasing upgrades and improvements carried out in walls & roofing products.
The European region is projected to exhibit robust growth and generate healthy revenue in the coming years, followed by Asia Pacific region, which is also predicted to grow considerably over the forecast period.
Prominent players in the industry include General Electric, Johnson Controls, Schneider Electric, SunPower Corporation, and Autodesk, Inc., among others.

Patient Temperature Management Market Worth $5.0 Billion By 2026

The global patient temperature management market size is anticipated to reach a value of USD 5.0 billion by 2026, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 8.5% during the forecast period. A rising number of surgeries is anticipated to accelerate the demand for temperature management devices. For instance, open heart surgeries require lowering down the body heat of patients through blood cooling, which helps reduce the risk of the post and perioperative surgical complications.

With the growing prevalence of cardiac arrest and other chronic cardiac diseases, there is a rising number of surgeries being undertaken. This growth is anticipated to drive the need for patient temperature management, to avoid the adverse effects on the brain. Patient warming systems are also used for cancer patients as adjuncts with chemotherapy and radiation therapy for more effective results. Moreover, in neonatal care, newborns are likely to experience temperature fluctuations and hence, they are kept in incubators to maintain their normal body temperature. The aforementioned factors are driving demand for temperature monitoring devices.

With the rising demand for conventional warming and cooling devices, there is a growing need for modern temperature management systems. The introduction of a wide range of surface warming and cooling systems by major companies is expected to positively impact the market growth during the forecast period. The blood and fluid temperature management devices have also evolved over the years and are applied through a catheter by circulating warm or cool saline in the patients’ body.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/patient-temperature-management-market

Further Key Findings From the Study Suggest:

Patient warming systems led the market in 2018 due to a rise in the number of surgeries, which lower the body temperature of patients due to the use of general anesthesia
Patient cooling systems are anticipated to exhibit a lucrative CAGR over the forecast period due to the introduction of new products like cooling caps and blood and fluid cooling systems
Surgery segment held the largest market share in 2018 due to the increasing number of cardiac and gynecological surgeries across the globe
Operating rooms segment is expected to generate huge revenue due to a large number of surgical procedures being performed and the need for temperature management during these surgeries
In 2018, North America led the patient temperature management market due to rising demand for technologically advanced products in this region
Asia Pacific is expected to showcase lucrative growth over the forecast period, due to increasing sedentary lifestyle resulting in cardiac-related disorders
Some of the major companies operating in the market include Stryker Corporation; ZOLL Medical Corporation; Cincinnati Sub-Zero Products, LLC; Medtronic, Inc.; 3M Company; Bard Medical, Inc.; and The 37Company

Contrast Media Market Size Worth $6.9 Billion By 2027

The global contrast media market size is expected to reach USD 6.9 billion by 2027, exhibiting a CAGR of 3.6% during the forecast period, according to a new report published by Grand View Research, Inc. Increasing burden of chronic diseases is driving the demand for diagnostic imaging procedures which are anticipated to fuel the contrast agents market growth.

The imaging tests such as Computed Tomography (CT), Magnetic Resonance Imaging (MRI), and x-rays have become an inevitable part of diagnosis for most of the diseases. The large-scale penetration of imaging technology in healthcare has increased the demand for contrast media. Newer contrast agents are constantly being discovered and investigated. Also, the safety of contrast agents for clinical use is under strict scrutiny.

The rapid rise in the use of medical imaging during the last few decades has resulted in a substantial increase in the use of radiologic contrast media. Half of the around 76.0 million computed tomographic and 34.0 million magnetic resonance imaging examinations performed annually include the use of intravenous contrast agents.

Diagnostic imaging modalities are being increasingly used owing to advancements in the underlying technology, ranging from equipment to administration technology. Innovative products such as syringeless injectors help achieve greater accuracy in delivering the right dose of contrast agents as well as reduce wastage. These injectors enable shorter examination time, leading to increased patient throughput. In 2016, the first syringeless injector was launched by Bracco Diagnostics in U.S.for multi-patient use to increase the number of scans performed in a day.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/contrast-media-contrast-agents-market

Further Key Findings from the Study Suggest:

Iodinated contrast media was the largest segment in 2019 and is anticipated to remain dominant over the forecast period as the products have excellent radio-opacity and low toxicity
X-ray/ CT was the largest modality segment in 2019, in terms of revenue share, owing to wide acceptance and cost-efficiency of the techniques
Cardiovascular diseases is projected to witness the fastest growth over the forecast period due to label extensions for ultrasound and X-ray/ CT contrast agents in U.S. For instance, in 2016, the U.S. FDA approved Lumason for use in liver ultrasonography
North America dominated the contrast media/contrast agents market with the largest revenue share of 44.3% in 2019 owing to the presence of well-established healthcare infrastructure and availability of advanced technology
Some of the key players operating in the market are Bayer AG; General Electric Company; Guerbet; Lantheus Medical Imaging, Inc.; Bracco Diagnostic, Inc.; Trivitron Healthcare; nano Therapeutics Pvt. Ltd.; and iMAX

Population Health Management Market Worth $150.6 billion By 2027

The global population health management market is expected to reach USD 150.6 billion by 2027, registering a CAGR of 21.1% over the forecast period, according to a new report by Grand View Research, Inc. The need for population health services that combine multiple functionalities is increasing due to the complex nature of care delivery and payment models. Population health management (PHM) solutions can process clinical, financial, and operational data that help improve efficiency and patient care. The health management program is also witnessing changes in medical reimbursement due to increasing emphasis on value-based payment (VBP) and Accountable Care Organizations (ACOs). In addition, the convenience offered by value-based payment models is responsible for the increased adoption of population health solutions by ACOs.

ACOs, consisting of hospitals, clinics, and other healthcare providers, collaborate with the payers (private and public) to provide high quality care to the patients. Private and public insurance providers have introduced various disease management programs that help in the treatment of chronic illnesses. These multidisciplinary efforts are expected to result in efficient treatment outcomes and are likely to suggest the best suitable courses of action that need to be undertaken. Successful large-scale trials in U.S. have enabled significant advancements in disease management programs.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/population-health-management-phm-market

Further key findings from the report suggest:

PHM software offers predictive data analytics, which can be applied for interpreting population characteristics from unstructured clinical data
The services product segment held a majority of the market share in 2019, as healthcare providers prefer in-house maintenance services
Healthcare providers held the largest market share of the end-use segment in 2019. The providers can focus effectively on patient-centric care and reducing overall costs
North America was the largest regional market in 2019 and is likely to retain its position over the forecast period, as the providers, payers, providers-payers, and accountable care organizations promote the use of PHM services
Asia Pacific population health management market is expected to witness the fastest growth in the coming years due to rising healthcare expenditure and improving healthcare infrastructure in the region
Allscripts, McKesson Corporation, and Cerner Corporation are some of the key PHM market players. Acquisitions and business partnerships with other market players are some of the strategic initiatives undertaken by these companies to strengthen their market presence

Neurovascular Devices Market Worth $3.9 Billion By 2027

The global neurovascular devices market size is anticipated to reach USD 3.9 billion by 2027, registering a CAGR of 5.6% over the forecast period, according to a new report by Grand View Research, Inc. Rising demand for minimally invasive procedures, increasing incidence of neurological disorders, and introduction of technologically advanced products are driving the growth of neurovascular devices.

Increasing incidence of neurological conditions such as stroke and brain aneurysm, cerebral artery stenosis, and stroke are fueling the market growth. For instance, according to the Stroke Association, more than 100,000 people suffer from stroke every year in U.K. and stroke costs are up to USD 33.7 billion per year.

Decreased postoperative pain and speedy recovery are leading to increasing adoption of minimally invasive surgeries and triggering growth of R&D in this field. Several key players are investing in R&D for the launch of innovative minimally invasive surgical instruments, especially got the neurovascular diseases. The endovascular coiling used for the treatment of intracranial aneurysm is one of the minimally invasive procedures widely recommended by the physicians.

Furthermore, increasing number of technologically advanced product launches by the key market players are also contributing to the market growth. For instance, in January 2018, CERENOVUS, launched Galaxy G3 mini coil, the softest and smallest embolic finishing coil used in the treatment of hemorrhagic stroke and intracranial aneurysm.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/neurovascular-devices-market

Further Key Findings from the Study Suggest:

The cerebral embolization and aneurysm coiling devices segment dominated the neurovascular devices market in 2019 owing to increasing demand for minimally invasive procedures and rising incidence of cerebral artery stenosis
Based on therapeutic application, the stroke segment dominated the market in 2019 owing to increasing prevalence of stroke worldwide, awareness initiatives by various government and non-government organizations, and introduction of technologically advanced products
North America dominated the market with the highest revenue share in 2019 owing to increasing prevalence of stroke and brain aneurysm, increasing disposable income, and presence of key players in the region
Some of the major players operating in the market are Medtronic; Microport Scientific Corporation; Penumbra, Inc.; Stryker; Johnson and Johnson Services Inc.; Microvention Inc.; and Codman Neuro

Pediatric Imaging Market Worth $12.2 Billion By 2027

The global pediatric imaging market size is expected to reach USD 12.2 billion by 2027, registering a CAGR of 7.6% over the forecast period, according to a new report by Grand View Research, Inc. Increasing incidences of pediatric trauma cases are expected to accelerate the demand for innovative patient screening, which is expected to augment the market growth.

According to the Centers for Disease Control and Prevention (CDC), an estimated 812,000 children aged 17 or below were treated in the U.S. Emergency Department (ED) for concussion or Traumatic Brain Injury (TBI) in 2014. CDC further stated that injuries due to falling accounted for an approximate 49% of all TBI-related ED visits in children. In addition, increasing focus of market players on product development and innovation is expected to drive the market growth. For instance, in June 2019, Carestream Health, Inc. launched a portable Carestream DRX Plus 2530C X-ray detector with cesium iodide technology, which captures minute details of anatomical structures in pediatric patients.

North America accounted for the largest share in 2019 owing to favorable reimbursement policies, faster adoption of innovative imaging modalities, and growing consumer preference toward noninvasive diagnosis. Increasing investments in order to propel technological innovation is expected to augment the pediatric imaging market growth in the region. For instance, in 2018, Bracco Diagnostics Inc. provided a grant of USD 300,000 to Children’s Hospital of Philadelphia (CHOP), to fund research and train technicians to use a new technology of contrast ultrasound. Also, medical coverage is granted by the Children’s Health Insurance Program (CHIP) for pediatric patients in U.S., which covers imaging services, is a major factor propelling the market growth.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/pediatric-imaging-market

Further key findings from the report suggest:

The magnetic resonance imaging modality segment dominated the market owing to high usage in hospital settings and higher recommendations by radiologists due to safety
By application, the orthopedic/ trauma segment is expected to register the highest CAGR due to rising incidence of bone defects in children combined with increasing cases of ED visits related to trauma
By end user, the hospital segment accounted for the largest market share owing to large number of installed systems in hospital settings and direct collaborations of hospitals with market vendors, thereby offering access to novel and advanced imaging systems
Leading players present in the pediatric imaging market include GE Healthcare; Siemens Healthineers AG; Koninklijke Philips N.V. (Royal Philips); Fujifilm Holdings Corporation; Toshiba Medical Systems Corporation; Samsung Electronics Co., Ltd.; Agfa Healthcare; and Carestream Health, Inc.